Retatrutide (LY3437943) is a triple agonist peptide targeting glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor. This high purity compound shows potential for research in weight management and metabolic disorders.
Our pharmaceutical-grade Retatrutide is supplied as white lyophilized powder with purity exceeding 99%. The product is carefully packaged to ensure stability during storage and transportation.
For research institutions and wholesale buyers, we offer flexible customization options including various vial sizes (2mg, 5mg, 10mg, 15mg, 20mg, 30mg, 50mg) and private label packaging. All batches come with complete Certificate of Analysis documentation.
Storage requirements: Maintain at or below -20°C in lyophilized form. Proper handling and storage are essential to preserve the compound's research properties.
Note: This product is for research use only, not for human consumption. All transactions are subject to verification of intended research purpose.